Publications by authors named "Vagif Atduev"

Claim this Profile
F
First-line Pembrolizumab Plus Lenvatinib for Advanced Non-clear-cell Renal Cell Carcinoma: Updated Results from the Phase 2 KEYNOTE-B61 Trial.
Martin H Voss, Howard Gurney, Vagif Atduev, Cristina Suarez, Miguel A Climent

Eur Urol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD37-09 The First Report Of Disease-Free Survival Analyses From The Niagara Trial Of Perioperative Durvalumab Plus Neoadjuvant Chemotherapy In Muscle-Invasive Bladder Cancer: Erratum.
Joshua J Meeks, Michiel S van der Heijden, Thomas Powles, Matthew D Galsky, Hikmat Al-Ahmadie, Vagif Atduev

J Urol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of pembrolizumab in patients with advanced urothelial carcinoma deemed potentially ineligible for platinum-containing chemotherapy: Post hoc analysis of KEYNOTE-052 and LEAP-011.
Peter H O'Donnell, Yohann Loriot, Tibor Csoszi, Nobuaki Matsubara, Sang Joon Shin, Vagif Atduev

Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer.
Thomas Powles, James W F Catto, Matthew D Galsky, Hikmat Al-Ahmadie, Joshua J Meeks, Vagif Atduev

N Engl J Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab with or Without Lenvatinib as First-line Therapy for Patients with Advanced Urothelial Carcinoma (LEAP-011): A Phase 3, Randomized, Double-Blind Trial.
Nobuaki Matsubara, Ronald de Wit, Arjun Vasant Balar, Arlene O Siefker-Radtke, Jakub Zolnierek, Vagif Atduev

Eur Urol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial.
Laurence Albiges, Howard Gurney, Vagif Atduev, Cristina Suarez, Miguel A Climent

Lancet Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): a multicentre, randomised, double-blind, phase 3 trial.
Christopher Sweeney, Sergio Bracarda, Cora N Sternberg, Kim N Chi, David Olmos, Vagif Atduev

Lancet· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced enteral therapy in acute pancreatitis: is there a room for immunonutrition? A meta-analysis.
Maxim S Petrov, Vagif A Atduev, Vladimir E Zagainov

Int J Surg· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis